atheroma

(redirected from Atherosclerotic plaque)
Also found in: Dictionary, Medical, Encyclopedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Words related to atheroma

a fatty deposit in the intima (inner lining) of an artery

References in periodicals archive ?
Kong et al., "Simvastatin increases prolyl4-Hydroxylase [alpha]1 expression in atherosclerotic plaque and oxLDL-stimulated human aortic smooth muscle cells via p38 MAPK and ERK1/2 signaling," Journal of Molecular and Cellular Cardiology, vol.
These systems use a diamond-coated crown, attached to an orbiting shaft, which targets atherosclerotic plaque while preserving healthy vessel tissue, a critical factor in preventing reoccurrences.
HMGB1 is associated with atherosclerotic plaque composition and burden in patients with stable coronary artery disease.
The hypothesis of the initiating process starting in the wall of the artery and the injury healing cycle in a vulnerable site providing the ongoing stimulus that perpetuates the formation of the atherosclerotic plaques deserves investigation.
Burke et al., "Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage," Arteriosclerosis, Thrombosis, and Vascular Biology, vol.
Thomas, "Vulnerable atherosclerotic plaque metalloproteinases and foam cell phenotypes," Thrombosis and Haemostasis, vol.
T-cell cytokine and chemokine production has an important role in the progression of the atherosclerotic plaque. Several cytokines are targeted by miR-155 in [CD4.sup.+] T cells, and mice with miR-[155.sup.-/-] are immunodeficient (53).miRNA-155 is also needed for the survival of regulatory T cells and for the T-helper 17 response (54).
(31-33) Regardless of the effects of these traditional risk factors on the development of the atherosclerotic plaque, a growing body of evidence demonstrates their impact on rupture-induced occlusion.
Given the role of inflammation in atherosclerotic plaque destabilization, immune suppressive medication like mycophenolate mofetil may counteract the increased postoperative risk for vascular events [39].
One is still left with an underlying atherosclerotic plaque that can disrupt and cause symptoms or acute events.
(OTCBB: AHR.), Irvine, Calif., a biotech company focused on the research and development of compounds to regress atherosclerotic plaque, has released financial results for fiscal 2011.
A mixed atherosclerotic plaque was seen in the projection of posterior wall of the right internal carotid artery mouth causing stenosis of lumen for 65% in diameter or 87% in area.
The biotech's international research teams believe that CER-001 has the potential to rapidly regress atherosclerotic plaque.
(2) Despite our longstanding awareness of atherosclerosis and its association with myocardial infarction and sudden cardiac death, only recently have we been able to study the pathology and progression of atherosclerotic plaque formation.
Full browser ?